Ui Wook Hwang | Biology and Life Sciences | Research Excellence Award

Research Excellence Award

Ui Wook Hwang
Kyungpook National University, South Korea
Ui Wook Hwang
Affiliation Kyungpook National University
Country South Korea
Scopus ID 35074015800
Documents 134
Citations 2117
h-index 26
Subject Area Biology and Life Sciences
Event Top Teachers Awards
ORCID 0000-0002-9735-8716
Google Scholar 5YycGS0AAAAJ

Ui Wook Hwang is a senior academic researcher and professor affiliated with the Department of Biology and the Department of Advanced Bioconvergence at Kyungpook National University, South Korea. His scholarly work primarily focuses on molecular phylogenetics, evolutionary biology, zoology, mitochondrial genomics, and biodiversity research. His academic profile demonstrates sustained contributions to biological sciences through publication activity, institutional leadership, international collaboration, and scientific service within Korea and the broader international research community.[1]

Abstract

This article presents an academic overview of the professional achievements, research contributions, and scholarly activities of Ui Wook Hwang of Kyungpook National University. His research portfolio encompasses molecular evolution, mitochondrial genomics, phylogenetics, marine biology, zoology, and biodiversity science. The profile also highlights his institutional leadership roles, publication record, international collaborations, and participation in scientific organizations relevant to the biological sciences community.[1]

Keywords

Molecular phylogenetics, evolutionary biology, mitochondrial genomics, zoology, biodiversity science, marine biology, taxonomy, genomic epidemiology, biological systematics, phylogeography.

Introduction

Ui Wook Hwang has maintained a multidisciplinary academic career centered on evolutionary biology and molecular systematics. His research activities integrate genomic analysis, biodiversity investigation, and evolutionary interpretation within zoological and biological sciences. In addition to scientific publication activities, he has held numerous academic leadership positions at Kyungpook National University and within national scientific organizations in the Republic of Korea.[2]

His academic development includes international scholarly experience as a visiting scholar at Harvard University and research training in Germany. These experiences contributed to the development of an internationally engaged research profile emphasizing molecular evolution and comparative genomics.[3]

Research Profile

The academic profile of Ui Wook Hwang demonstrates sustained engagement in higher education, research administration, and scientific leadership. His professional positions include Full Professor and Chair of the Department of Biology at Kyungpook National University, Chair of the Department of Advanced Bioconvergence, Director of the Institute for Phylogenomics and Evolution, and Director of the Korea Herb-Bio Convergence Promotion Institute.[2]

  • Full Professor and Chair, Department of Biology, Kyungpook National University.
  • Chair, Department of Advanced Bioconvergence, Graduate School, Kyungpook National University.
  • Director, BK21 Four KNU Center for Innovative One-Health Leaders.
  • President, The Malacological Society of Korea.
  • Former President, Korean Society of Systematic Zoology.

Research Contributions

The research contributions of Ui Wook Hwang are associated with molecular phylogenetics, mitochondrial genome evolution, marine biodiversity, and evolutionary genomics. His work has contributed to the understanding of species evolution, phylogeographic patterns, and genomic diversity across marine and terrestrial organisms.[4]

His publications include studies on mitochondrial genome evolution in parasitic barnacles, molecular population genetics in East Asian marine species, and genomic analysis of mosquito vectors. Several studies have appeared in internationally indexed journals including Nature, Molecular Biology and Evolution, and Frontiers in Marine Science.[5]

  • Research on mitochondrial genome-based systematics and evolution.
  • Studies concerning marine biodiversity and zoological taxonomy.
  • Comparative genomic investigations in parasitic and marine organisms.
  • Scientific communication related to global bioinformatics and genomic epidemiology.

Publications

Ui Wook Hwang has contributed extensively to molecular phylogenetics, mitochondrial genomics, marine biodiversity, and evolutionary biology through publications in internationally recognized scientific journals. His research explores genomic evolution, phylogeographic diversity, and biological systematics, supporting ongoing advancements in zoological and evolutionary science while strengthening interdisciplinary understanding within contemporary biological research.[4]

  1. Morphology and mitochondrial genome-based analysis of the systematics and evolution of Acanthochitona species. Marine Life Science & Technology, 2026. DOI: https://link.springer.com/article/10.1007/s42995-026-00362-9
  2. Evolutionary insights from complete mitochondrial genomes of Aedes albopictus and Culex pipiens molestus. Animal Cells and Systems, 2026. DOI: https://doi.org/10.1080/19768354.2026.2620255
  3. Accelerated mitochondrial genome evolution in parasitic barnacles driven by adaptive and non-adaptive responses. Molecular Biology and Evolution, 2025. DOI: https://doi.org/10.1093/molbev/msaf303
  4. Molecular population genetics and phylogeographic studies of Ligia exotica and Ligia cinerascens in East Asia. Frontiers in Marine Science, 2023. DOI: https://doi.org/10.3389/fmars.2023.1260171
  5. Africa needs more bioinformaticians for population studies. Nature, 2022. DOI: https://doi.org/10.1038/d41586-022-01378-8

Research Impact

The research output of Ui Wook Hwang reflects measurable academic impact within the biological sciences community. His Scopus profile records more than two thousand citations and an h-index of 26, indicating continuing scholarly engagement with his publications across multiple research domains.[1]

His interdisciplinary work linking molecular phylogenetics, biodiversity studies, and genomic analysis contributes to broader scientific understanding in evolutionary biology and zoological systematics. Participation in scientific advisory boards, research foundations, and educational initiatives further reflects his role within academic leadership and scientific administration.[2]

Award Suitability

Ui Wook Hwang has demonstrated significant contributions to scientific research, higher education, and international academic collaboration through his scholarly publications, leadership roles, and work in biological and evolutionary sciences.[3]

His involvement in multidisciplinary biological research, mentorship initiatives, institutional leadership, and internationally indexed scientific publications supports consideration within the framework of the Top Teachers Awards and similar academic recognition programs.[5]

Conclusion

Ui Wook Hwang has developed a substantial academic profile characterized by contributions to molecular evolution, phylogenetics, biodiversity science, and higher education leadership. His scholarly publications, institutional responsibilities, and participation in scientific organizations collectively illustrate a sustained commitment to biological sciences research and academic advancement within both national and international contexts.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Ui Wook Hwang, Author ID 35074015800. Scopus. https://www.scopus.com/authid/detail.uri?authorId=35074015800
  2. Kyungpook National University. (n.d.). Department of Advanced Bioconvergence and Faculty Information. https://www.knu.ac.kr/
  3. ORCID. (n.d.). Ui Wook Hwang ORCID Record. https://orcid.org/0000-0002-9735-8716
  4. Frontiers Media SA. (2023). Molecular population genetics and phylogeographic studies of Ligia exotica and Ligia cinerascens in East Asia. https://doi.org/10.3389/fmars.2023.1260171
  5. Nature Publishing Group. (2022). Africa needs more bioinformaticians for population studies. https://doi.org/10.1038/d41586-022-01378-8

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.

Małgorzata Burzyńska | Biomedicines | Research Excellence Award

Assist. Prof. Dr. Małgorzata Burzyńska | Biomedicines | Research Excellence Award

Wroclaw Medical University | Poland

Assist. Prof. Dr. Małgorzata Burzyńska is an Assistant Professor at the Wroclaw Medical University, specializing in anesthesiology and intensive care. With over two decades of clinical experience, her expertise focuses on severe central nervous system pathologies, particularly traumatic brain injury and aneurysmal subarachnoid hemorrhage. She has led and contributed to multiple nationally funded research projects on cerebral autoregulation, early brain injury, and neurocritical care monitoring, advancing understanding of neurological complications and patient outcomes. Dr. Burzyńska actively collaborates with biomedical engineering and signal processing groups, fostering interdisciplinary innovation. As a lecturer and frequent speaker at international conferences, she contributes to postgraduate education and professional development. Her work supports improved critical care strategies, enhancing survival and quality of life for patients with life-threatening neurological conditions.

Citation Metrics (Scopus)

300
225
150
75
0

Citations
280

h-index
10

Documents
29

Citations

h-index

Documents

Featured Publications

Adrianna Lebiedzińska, Małgorzata Burzyńska, Jowita Woźniak, Waldemar Goździk (2026).
The Prognostic Significance of Low-Triiodothyronine Syndrome in Aneurysmal Subarachnoid Hemorrhage
Biomedicines | Journal Article · 2026

Agnieszka Uryga, Marek Czosnyka, Magdalena Kasprowicz, Małgorzata Burzyńska, Barbara Dragan, Karol Budohoski, Nathalie Nasr (2025). Can ‘noisy data’ perform as well as ‘clean data’ in outcome modeling after aneurysmal subarachnoid haemorrhage?
Autonomic Neuroscience | Journal Article · 2025

Małgorzata Burzyńska, Jowita Woźniak, Piotr Urbański, Jarosław Kędziora, Rafał Załuski, Waldemar Goździk, Agnieszka Uryga (2025).
Heart Rate Variability and Cerebral Autoregulation in Patients with Traumatic Brain Injury with Paroxysmal Sympathetic Hyperactivity Syndrome
Neurocritical Care | Journal Article · 2025

Małgorzata Burzyńska (2025).
Nosocomial Infection after Aneurysmal Subarachnoid Hemorrhage
Conference: Postępy w Anestezjologii i Intensywnej Terapii | Conference Paper · 2025

Małgorzata Burzyńska (2025).
Relationship between Autonomic Nervous System Activity, Cerebral Autoregulation and Brain Biomarkers after Traumatic Brain Injury
Conference: Postępy w Anestezjologii i Intensywnej Terapii | Conference Paper · 2025

Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Dr. Mohammad Uddin | Medicine and Health Sciences | Research Excellence Award

Hamamatsu University School of Medicine | Bangladesh

Dr. Mohammad Khaja Mafij Uddin is an Associate Scientist in the Infectious Diseases Division at icddr,b, with over 15 years of expertise in mycobacteriology and tuberculosis (TB) diagnostics. His work integrates molecular, microbiological, and immunological approaches to advance TB detection, drug resistance analysis, and biomarker discovery. He has led and contributed to multiple internationally funded projects, including collaborations with organizations in France, Korea, and the USA, focusing on innovative diagnostics such as targeted next-generation sequencing and non-respiratory TB detection. Dr. Uddin has authored several peer-reviewed publications in high-impact journals, contributing significantly to understanding TB transmission dynamics and extrapulmonary TB. He has mentored graduate students and strengthened laboratory capacity, with his research directly supporting improved TB diagnosis and public health outcomes in high-burden settings.

Citation Metrics (Scopus)

94
75
50
25
0

Citations
94

h-index
4

Documents
5

Citations

h-index

Documents

Featured Publications

Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Assoc. Prof. Dr. Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Saitama University | Japan

Assoc. Prof. Dr. Yuki Hasegawa research focuses on advancing sensor technology and measurement systems with strong emphasis on gas sensors, taste sensors, electrochemical sensing, and plant bioelectrical potential measurement for environmental and agricultural applications. Core contributions include the design, fabrication, and evaluation of functional material–based sensors and miniaturized sensing platforms capable of stable, sensitive, and reproducible measurements under real-world conditions. Innovative experimental methodologies and signal analysis techniques have been developed to improve sensor selectivity, long-term stability, and response reliability. Research outcomes support interdisciplinary applications spanning environmental monitoring, smart agriculture, and bio-sensing systems, enabling more accurate detection of chemical and biological signals. The work integrates electrical engineering principles with materials science and measurement engineering, contributing to scalable and practical sensing solutions. Findings have been disseminated through high-impact peer-reviewed international journals and conferences indexed in SCI/SCIE and Scopus, strengthening global knowledge exchange in sensing technologies. Scholarly impact is reflected through citation metrics, with 306 total citations (124 since 2020), an h-index of 9 (6 since 2020), and an i10-index of 9 (2 since 2020), demonstrating consistent research influence and relevance. Overall, the research advances next-generation sensing systems and supports sustainable technological development in environmental and agricultural engineering.

Citation Metrics (Google Scholar)

Total Citations
306

Citations: 306 |
h-index: 9 |
i10-index: 9

🟦 Citations    🟩 h-index    🟥 i10-index


View Google Scholar Profile

Featured Publications

Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Dr. Stylianos Bourmpoutelis | Health Sciences | Young Scientist Award

Aristotle University of Thessaloniki | Greece

Dr. Stylianos Bourmpoutelis is an emerging researcher in Internal Medicine whose work is strongly centered on HIV medicine, antimicrobial resistance, and the clinical–microbiological interfaces shaping modern infectious disease care. His research activity reflects a sustained commitment to improving patient outcomes through evidence-based clinical strategies, with particular emphasis on vulnerable populations such as people who inject drugs. His contributions include data collection, clinical evaluation, and outcome-driven analysis that support impactful publications in peer-reviewed journals. Bourmpoutelis has participated in multidisciplinary research networks, contributing to studies that integrate public health, infectious diseases, and microbiology in order to optimize care pathways and improve treatment adherence. His scholarly visibility continues to grow through citations in reputable databases and the ongoing expansion of his indexed publications. He maintains active research profiles and consistently updates citation-related documents to ensure transparency and accessibility for the scientific community. Current citation metrics include an estimated Scopus h-index of 2 and a Google Scholar h-index of 3, reflecting the early yet steadily increasing influence of his work. His documented contributions demonstrate strong methodological engagement, rigorous data interpretation, and a readiness to collaborate across clinical and scientific teams. Bourmpoutelis’s research record aligns with the ideals of the Young Scientist Award, showcasing innovation, academic promise, and meaningful contributions to public health research. His scientific outputs emphasize integrated care models, real-world clinical outcomes, and microbiological investigations that collectively advance understanding within internal medicine and infectious disease research. With a growing portfolio of indexed publications and documented research contributions, he continues to establish himself as a dedicated early-career scientist advancing impactful, ethically grounded, and methodologically robust medical research.

Publication Profile

Google Scholar

Featured Publications

Roussos, S., Protopapapas, K., Mastrogianni, E., Totsikas, C., Moschopoulos, C. D., Bourmpoutelis, S., Resta, P., Procter, K., Kokolesis, E., Antoniadou, A., et al. (2025). Rapid ART initiation with BIC/FTC/TAF in people who inject drugs in Greece: Results from a pilot single-arm study of an integrated care model. Microorganisms, 13(12), 2697.

Abduljabbar S. Ba Mahel | Biomedical | Best Researcher Award

EMMANUEL SCALAIS | Medicine and Health Sciences | Outstanding Scientist Award

Dr.EMMANUELSCALAIS|MedicineandHealth Sciences| Outstanding Scientist Award

MD at NEPE, Luxembourg.

Dr. Emmanuel Scalais is the Chief Physician of the Pediatric Neurology Department at Centre Hospitalier de Luxembourg (CHL)He has authored 82 publications and has been cited 2,877 times in the field of pediatric neurology.His clinical expertise includes conditions such as homocystinuria, vitamin B12 deficiency anemia, and exocrine pancreatic insufficiency.

professional profiles📖

Education 🎓

Secondary School: Humanity Greco-Latine (June 1972), Collège du Sacré-Coeur, Charleroi, BelgiumHigh School: Université Catholique de LouvainBaccalauréat en Philosophie: Magna cum Laude (June 1975)Doctor of Medicine: Laude (June 1979)

work Experience💼

1988-2002: Pediatric Neurologist, CHC Espérance & Saint Vincent, Liège, Belgium (Full-time)Lecturer: Pediatric Neurology Course for nurses at “School of Sainte-Julienne,” LiègeLecturer: “Medical Approach of Handicap” in Orthopédagogie2003-2024: Pediatric Neurologist, Centre Hospitalier de Luxembourg, Department of Pediatrics (Full-time)Head of Pediatric Neurology Division (2014-2018, 2018-2024)Lecturer: Pediatric Neurology Course for nurses at “Lycée Technique pour Professions de Santé” (2006-2024)

Research Focus

Dr. Scalais has authored numerous peer-reviewed articles, with a focus on pediatric neurology, metabolic disorders, and neonatal brain function. Notable contributions include:Research on phenobarbital’s effects on cerebral blood flow in newbornsStudies on very long-chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant deathInvestigations into early myoclonic epilepsy linked to CoQ10 deficiencyDiagnostic and prognostic value of evoked potentials in neonatal hypoxiaCase studies on mitochondrial disorders, such as Leigh’s encephalopathy and POLG mutationsHydroxocobalamin dose intensification in early-onset cobalamin metabolism defects

Conclusion

Dr. Scalais based on his , , and . While increasing could further strengthen his profile, his current body of work already demonstrates and .is highly suitable for this awardsignificant contributions to pediatric neurology researchclinical impactinternational collaborationshigh-impact publications, principal investigator roles, and research fundingoutstanding scientific meritlong-term dedication to pediatric neurology

📚Publications to Noted

  • Scalais E, Beharry K, Papageorgiou A, Bureau M, Aranda JV (1992). Effects of phenobarbital on cerebral blood flow in the newborn piglet. Developmental Pharmacology and Therapeutics, 19(1), 10-18. [doi: 10.1159/000457457]

  • Scalais E, Bottu J, Wanders RJ, Ferdinandusse S, Waterham HR, De Meirleir L (2015). Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis. American Journal of Medical Genetics Part A, 167A(1), 211-214. [doi: 10.1002/ajmg.a.36803]

  • Scalais E, Chafai R, Van Coster R, Bindl L, Nuttin C, Panagiotaraki C, Seneca S, Lissens W, Ribes A, Geers C, Smet J, De Meirleir L (2013). Early myoclonic epilepsy, hypertrophic cardiomyopathy and subsequently a nephrotic syndrome in a patient with CoQ10 deficiency caused by mutations in para-hydroxybenzoate-polyprenyl transferase (COQ2). European Journal of Paediatric Neurology, 17(6), 625-630. [doi: 10.1016/j.ejpn.2013.05.013]

  • Scalais E, Connerotte AC, Despontin K, Biver A, Ceuterick-de Groote C, Alders M, Kolivras A, Hachem JP, De Meirleir L (2016). Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype. American Journal of Medical Genetics Part A, 170(7), 1799-1805. [doi: 10.1002/ajmg.a.37673]

  • Scalais E, Francois A, Nuttin C (1996). [Diagnostic and prognostic value of evoked potentials facing cerebral hypoxia in newborn infants]. Archives de Pédiatrie, 3 Suppl 1, 251s-253s. [doi: 10.1016/0929-693x(96)86058-1]

  • Scalais E, Francois B, Schlesser P, Stevens R, Nuttin C, Martin JJ, Van Coster R, Seneca S, Roels F, Van Goethem G, Lofgren A, De Meirleir L (2012). Polymerase gamma deficiency (POLG): clinical course in a child with a two-stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh’s encephalopathy. European Journal of Paediatric Neurology, 16(5), 542-548. [doi: 10.1016/j.ejpn.2012.01.013]

  • Scalais E, Francois-Adant A, Nuttin C, Bachy A, Guerit JM (1998). Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns. Electroencephalography and Clinical Neurophysiology, 108(2), 199-207. [doi: 10.1016/s0168-5597(97)00076-2]

  • Scalais E, Geron C, Pierron C, Cardillo S, Schlesser V, Mataigne F, Borde P, Regal L (2023). Would early versus late hydroxocobalamin dose intensification treatment prevent cognitive decline, macular degeneration and ocular disease in 5 patients with early-onset cblC deficiency? Molecular Genetics and Metabolism, 140(3), 107681. [doi: 10.1016/j.ymgme.2023.107681]

  • Scalais E, Nuttin C, Seneca S, Smet J, De Paepe B, Martin JJ, Stevens R, Pierart F, Battisti O, Lissens W, De Meirleir L, Van Coster R (2007). Infantile presentation of the mitochondrial A8344G mutation. European Journal of Neurology, 14(11), e3-5. [doi: 10.1111/j.1468-1331.2007.01926.x]

  • Scalais E, Osterheld E, Geron C, Pierron C, Chafai R, Schlesser V, Borde P, Regal L, Laeremans H, van Gassen KLI, van den Heuvel LPWJ, De Meirleir L (Under revision). Parenteral Hydroxocobalamin Dose Intensification in 5 Patients with Different Types of Early Onset Intracellular Cobalamin Defects: Clinical and Biochemical Responses. Journal of Inherited Metabolic Disease.